Startups
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 12, 2025 | Modulight Biotherapeutics Inks $12M Seed Funding | BOSTON, MA, Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced the closing of its Seed funding round raising $12.2 million. >> Click here for more funding data on... |
| Modulight Bio | “HOME | Modulight.bio” |
Reviews 0
FAQ about Modulight Biotherapeutics
What has the press written about Modulight Biotherapeutics?
Parsers VC has collected 3 articles mentioning Modulight Biotherapeutics, among them “Modulight Biotherapeutics Inks $12M Seed Funding” (Nov 12, 2025) and “Modulight Bio”.
Is Modulight Biotherapeutics still active?
Yes, Modulight Biotherapeutics is active; its latest activity on Parsers VC dates from Aug 25, 2026.